(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
SELLAS Life Sciences Group, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Wednesday, April 23rd, 2025 | 2023 | John T. Burns Senior Vice President, Chief Financial Officer | 365,000 | 0 | 66,800 | 125,560 | 14,598 | 797,708 |
| Wednesday, April 23rd, 2025 | 2023 | John T. Burns Senior Vice President, Chief Financial Officer | 365,000 | 0 | 66,800 | 125,560 | 14,598 | 797,708 |
| Wednesday, April 23rd, 2025 | 2024 | John T. Burns Senior Vice President, Chief Financial Officer | 401,500 | 50,000 | 24,417 | 154,176 | 15,218 | 680,778 |
| Wednesday, April 23rd, 2025 | 2024 | John T. Burns Senior Vice President, Chief Financial Officer | 401,500 | 50,000 | 24,417 | 154,176 | 15,218 | 680,778 |
| Wednesday, April 23rd, 2025 | 2023 | Dragan Cicic, M. D. Senior Vice President, Chief Development Officer | 403,500 | 0 | 53,440 | 140,418 | 15,599 | 778,507 |
| Wednesday, April 23rd, 2025 | 2023 | Dragan Cicic, M. D. Senior Vice President, Chief Development Officer | 403,500 | 0 | 53,440 | 140,418 | 15,599 | 778,507 |
| Wednesday, April 23rd, 2025 | 2024 | Dragan Cicic, M. D. Senior Vice President, Chief Development Officer | 427,710 | 50,000 | 23,378 | 164,240 | 17,414 | 713,480 |
| Wednesday, April 23rd, 2025 | 2024 | Dragan Cicic, M. D. Senior Vice President, Chief Development Officer | 427,710 | 50,000 | 23,378 | 164,240 | 17,414 | 713,480 |
| Wednesday, April 23rd, 2025 | 2023 | Angelos M. Stergiou, M.D., Sc.D. h.c. President and Chief Executive Officer | 625,000 | 0 | 193,720 | 275,000 | 4,243 | 1,752,638 |
| Wednesday, April 23rd, 2025 | 2023 | Angelos M. Stergiou, M.D., Sc.D. h.c. President and Chief Executive Officer | 625,000 | 0 | 193,720 | 275,000 | 4,243 | 1,752,638 |
| Wednesday, April 23rd, 2025 | 2024 | Angelos M. Stergiou, M.D., Sc.D. h.c. President and Chief Executive Officer | 650,000 | 0 | 82,601 | 339,625 | 4,760 | 1,189,773 |
| Wednesday, April 23rd, 2025 | 2024 | Angelos M. Stergiou, M.D., Sc.D. h.c. President and Chief Executive Officer | 650,000 | 0 | 82,601 | 339,625 | 4,760 | 1,189,773 |
| Wednesday, April 30th, 2014 | 2013 | Brian Hamilton, M.D., Ph.D. Executive Vice President and Chief Medical Officer | 57,256 | 70,000 | 0 | 0 | 43 | 930,339 |
| Wednesday, April 30th, 2014 | 2013 | Brian Hamilton, M.D., Ph.D. Executive Vice President and Chief Medical Officer | 57,256 | 70,000 | 0 | 0 | 43 | 930,339 |
| Wednesday, April 30th, 2014 | 2012 | Brian Hamilton, M.D., Ph.D. Executive Vice President and Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 30th, 2014 | 2012 | Brian Hamilton, M.D., Ph.D. Executive Vice President and Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 30th, 2014 | 2011 | Brian Hamilton, M.D., Ph.D. Executive Vice President and Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 30th, 2014 | 2011 | Brian Hamilton, M.D., Ph.D. Executive Vice President and Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 30th, 2014 | 2013 | Rosemary Mazanet, M.D., Ph.D. Former Executive Vice President and Chief Medical Officer | 390,000 | 0 | 0 | 0 | 693 | 913,773 |
| Wednesday, April 30th, 2014 | 2013 | Rosemary Mazanet, M.D., Ph.D. Former Executive Vice President and Chief Medical Officer | 390,000 | 0 | 0 | 0 | 693 | 913,773 |
| Wednesday, April 30th, 2014 | 2012 | Rosemary Mazanet, M.D., Ph.D. Former Executive Vice President and Chief Medical Officer | 274,875 | 185,000 | 0 | 0 | 317 | 729,437 |
| Wednesday, April 30th, 2014 | 2012 | Mark J. Ahn, Ph.D. President and Chief Executive Officer | 447,930 | 217,000 | 0 | 0 | 693 | 1,007,463 |
| Wednesday, April 30th, 2014 | 2011 | Rosemary Mazanet, M.D., Ph.D. Former Executive Vice President and Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 30th, 2014 | 2011 | Rosemary Mazanet, M.D., Ph.D. Former Executive Vice President and Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 30th, 2014 | 2013 | Mark W. Schwartz, Ph.D. Executive Vice President and Chief Operating Officer | 365,000 | 125,000 | 0 | 0 | 693 | 1,583,640 |
| Wednesday, April 30th, 2014 | 2013 | Mark W. Schwartz, Ph.D. Executive Vice President and Chief Operating Officer | 365,000 | 125,000 | 0 | 0 | 693 | 1,583,640 |
| Wednesday, April 30th, 2014 | 2012 | Mark W. Schwartz, Ph.D. Executive Vice President and Chief Operating Officer | 350,000 | 105,000 | 0 | 0 | 693 | 551,613 |
| Wednesday, April 30th, 2014 | 2012 | Mark W. Schwartz, Ph.D. Executive Vice President and Chief Operating Officer | 350,000 | 105,000 | 0 | 0 | 693 | 551,613 |
| Wednesday, April 30th, 2014 | 2011 | Mark W. Schwartz, Ph.D. Executive Vice President and Chief Operating Officer | 235,673 | 108,177 | 0 | 0 | 213 | 568,327 |
| Wednesday, April 30th, 2014 | 2011 | Mark W. Schwartz, Ph.D. Executive Vice President and Chief Operating Officer | 235,673 | 108,177 | 0 | 0 | 213 | 568,327 |
| Wednesday, April 30th, 2014 | 2012 | Rosemary Mazanet, M.D., Ph.D. Former Executive Vice President and Chief Medical Officer | 274,875 | 185,000 | 0 | 0 | 317 | 729,437 |
| Wednesday, April 30th, 2014 | 2012 | Mark J. Ahn, Ph.D. President and Chief Executive Officer | 447,930 | 217,000 | 0 | 0 | 693 | 1,007,463 |
| Wednesday, April 30th, 2014 | 2011 | Mark J. Ahn, Ph.D. President and Chief Executive Officer | 320,680 | 257,746 | 0 | 0 | 225 | 1,248,766 |
| Wednesday, April 30th, 2014 | 2011 | Mark J. Ahn, Ph.D. President and Chief Executive Officer | 320,680 | 257,746 | 0 | 0 | 225 | 1,248,766 |
| Wednesday, April 30th, 2014 | 2013 | Mark J. Ahn, Ph.D. President and Chief Executive Officer | 487,030 | 250,000 | 0 | 0 | 693 | 3,099,363 |
| Wednesday, April 30th, 2014 | 2013 | Mark J. Ahn, Ph.D. President and Chief Executive Officer | 487,030 | 250,000 | 0 | 0 | 693 | 3,099,363 |
| Wednesday, April 30th, 2014 | 2013 | Ryan M. Dunlap Vice President, Chief Financial Officer | 195,028 | 41,000 | 0 | 0 | 366 | 684,410 |
| Wednesday, April 30th, 2014 | 2013 | Ryan M. Dunlap Vice President, Chief Financial Officer | 195,028 | 41,000 | 0 | 0 | 366 | 684,410 |
| Wednesday, April 30th, 2014 | 2012 | Ryan M. Dunlap Vice President, Chief Financial Officer | 80,994 | 60,000 | 0 | 0 | 144 | 233,118 |
| Wednesday, April 30th, 2014 | 2012 | Ryan M. Dunlap Vice President, Chief Financial Officer | 80,994 | 60,000 | 0 | 0 | 144 | 233,118 |
| Wednesday, April 30th, 2014 | 2011 | Ryan M. Dunlap Vice President, Chief Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 30th, 2014 | 2011 | Ryan M. Dunlap Vice President, Chief Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Monday, April 29th, 2013 | 2012 | Mark J. Ahn, Ph.D. President and Chief Executive Officer | 447,930 | 217,000 | 0 | 0 | 693 | 1,007,463 |
| Monday, April 29th, 2013 | 2012 | Mark W. Schwartz, Ph.D. Executive Vice President and Chief Operating Officer | 350,000 | 105,000 | 0 | 0 | 693 | 651,613 |
| Monday, April 29th, 2013 | 2011 | Mark J. Ahn, Ph.D. President and Chief Executive Officer | 320,680 | 257,746 | 0 | 0 | 225 | 1,148,766 |
| Monday, April 29th, 2013 | 2011 | Mark J. Ahn, Ph.D. President and Chief Executive Officer | 320,680 | 257,746 | 0 | 0 | 225 | 1,148,766 |
| Monday, April 29th, 2013 | 2012 | Mark J. Ahn, Ph.D. President and Chief Executive Officer | 447,930 | 217,000 | 0 | 0 | 693 | 1,007,463 |
| Monday, April 29th, 2013 | 2011 | Mark W. Schwartz, Ph.D. Executive Vice President and Chief Operating Officer | 235,673 | 108,177 | 0 | 0 | 213 | 568,327 |
| Monday, April 29th, 2013 | 2011 | Mark W. Schwartz, Ph.D. Executive Vice President and Chief Operating Officer | 235,673 | 108,177 | 0 | 0 | 213 | 568,327 |
| Monday, April 29th, 2013 | 2012 | Mark W. Schwartz, Ph.D. Executive Vice President and Chief Operating Officer | 350,000 | 105,000 | 0 | 0 | 693 | 651,613 |
| Wednesday, June 18th, 2008 | 2006 | Tod Woolf, Ph.D. President and Chief Executive Officer Stephen J. DiPalma Chief Financial Officer and Secretary | 0 | 0 | 0 | 0 | 115,830 | 115,830 |
| Wednesday, June 18th, 2008 | 2007 | James Warren Former Chief Financial Officer and Secretary Pamela Pavco, Ph.D. Vice President of Pharmaceutical Development Dmitry Samarsky, Ph.D. Vice President of Technology and Business Development | 216,347 | 87,500 | 0 | 0 | 33,302 | 573,582 |
| Wednesday, June 18th, 2008 | 2007 | James Warren Former Chief Financial Officer and Secretary Pamela Pavco, Ph.D. Vice President of Pharmaceutical Development Dmitry Samarsky, Ph.D. Vice President of Technology and Business Development | 216,347 | 87,500 | 0 | 0 | 33,302 | 573,582 |
| Wednesday, June 18th, 2008 | 2006 | Tod Woolf, Ph.D. President and Chief Executive Officer Stephen J. DiPalma Chief Financial Officer and Secretary | 0 | 0 | 0 | 0 | 115,830 | 115,830 |
